Puretech Health LLC (Puretech Health) is a venture capital firm subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston.

Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. The company’s extensive expertise in product development has been built over the past 20 years: initially as a stand alone development organization, then as a U.S. subsidiary of Shire plc and, upon its acquisition of substantially all the assets of Shire Laboratories Inc. in late 2005, as Supernus Pharmaceuticals. The company is developing several product candidates in neurology and psychiatry to address large market opportunities in epilepsy, ADHD and depression. In addition to its two ADHD product candidates, Supernus is developing two late stage epilepsy product candidates, SPN-538 (extended release topiramate), and Epliga® (extended release oxcarbazepine).

Shouguang Fukang Pharmaceutical Co. Ltd. is a Chinese private company that manufactures and distributes pharmaceutical ingredients.

Dr. R. Pfleger GmbH is a medium sized German pharmaceutical company located in Bamberg (Bavaria) with a staff of 300 employees. Established in 1945 as a private company, it is nowadays exclusively owned by the Doktor Robert Pfleger Foundation, which aims are the exclusive sponsoring of charitable and social projects and the support of medical research.

TCD Royalty Sub LLC is an American private company that engages in research, development and supply of pharmaceutical products.

Weifang Hekang Biotechnology Co., Ltd., established on 2012-03-28, Business scope includes research and development and transfer of biomedical technology.(The above scope is not prohibited by laws and regulations,restricted items,legally required to operate with a license,Operate with relevant license)(The lease contract is valid until2013year4moon22day)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Beijing Shutaishen Pharmaceutical Technology Co., Ltd., established on 2002-05-28, Business scope includes medical technology development,technology transfer,technical consulting,Technical Services.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Shutai Shen (Beijing) Biopharmaceutical is a company independently developed a new class of drugs. The company is mainly engaged in the R&D, production and marketing of innovative intellectual property rights. It belongs to the “C27 Pharmaceutical Manufacturing” category in the industry classification of listed companies of the China Securities Regulatory Commission. It is an early exploration research, drug discovery, process development and The pilot-scale amplification, pre-clinical biological evaluation, clinical development, pharmaceutical production and commercialization of the entire industry chain of innovative bio-pharmaceutical enterprises, with a complete system of research and development, production and marketing, is a national high-tech enterprise.

Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD.

Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA.

K.H.S. Pharma Holding GmbH is a private company headquartered in Ingelheim, Germany, with operations in France, that provides management services. It was founded in 1995. Silvia B��hler and Karl-Heinz Schleicher are the current co-CEOs of the firm.

Endo Pharmaceuticals Solutions, Inc. develops products to treat conditions in urology and endocrinology. The company was founded in 2009 and is headquartered in Malvern, PA.

Bridge Laboratories is a preclinical contract research organization (CRO) that provides US-level regulatory-compliant drug development services globally. Bridge is known for its extensive work in toxicology, including vaccines, and safety pharmacology. The company's AAALAC-accredited facility in China was among the first labs to perform GLP studies for clients worldwide.\nBridge Laboratories gives drug development clients-biotech/pharmaceutical firms, government agencies and virtual companies with strong outsourcing needs-a CRO choice that can dramatically improve the speed and cost-effectiveness of their drug development research programs.

Shouguang Yongkang Chemical Industry Co., Ltd., established on 2000-03-10, Business scope includes production,Sales:1,3-Bromochloropropane2000t/a,1-bromopropane4000t/a,1-bromobutane2200t/a,hydrobromic acid20000t/a,Ethyl bromide2000t/a,2-bromopropane600t/a,m-Aminophenol1200t/a,sulfuric acid15000t/a,hydrochloric acid3000t/a,Chlorosulfonic acid10000t/a,Acetanilide4000t/a,bromine500t/a(South Ring Road, Yangkou Town801No),bromine500t/a(East of Xingang Road, Yangkou Town),Sodium hypochlorite solution(Contains available chlorine>5%)10000t/a,hydrobromic acid2760t/a,Sodium methoxide methanol solution20000t/a;Operations without storage facilities(No samples on site,No warehouse,Only engaged in bill transaction business):Methanol,Butanol,1-propanol,4-First(benzene)phenol,3-First(benzene)phenol,sodium hydroxide solution(The validity period is subject to the license);Production,Sales:3,5-Dibromo-4-Hydroxybenzaldehyde,right-beta-Hydroxyethylsulfone aniline sulfate,3,4,5-Trimethoxybenzaldehyde3000t/a,Benzyl-2naphthyl ether3000t/a,1,2-Diphenoxyethane200t/a,2-Methyl-4-Methoxydiphenylamine1500t/a,Phenoxypolyphosphazene2000t/a,2-Anilino-3-Methyl-6-Dibutylaminofluoran1000t/a,Hexachlorotrimeric phosphazene2000t/a,2-bromine-5-Methoxytoluene2400t/a,1,3,5-Tribromobenzene300t/a,sodium bromide,Sodium Methyl Sulfate,3,4,5-trimethoxytoluene300t/a,1,3,5-trimethoxybenzene100t/a,Syringaldehyde100t/a(Operating with a license involving licensing);Operate the import and export business of goods and technologies within the scope permitted by the state(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments);(The following scope is limited to branch operations)Cardboard drum production***

ENZYCHEM LIFESCIENCES Corp. engages in developing, manufacturing, and distributing pharmaceutical products. Its main products include beta lactam antibiotics, non-beta lactam active pharmaceutical ingredient (APIs), and others. The beta lactam antibiotics include Cefazedone, Cefbuperazone and Ceftizoxime. The non-beta lactam APIs include D-cycloserine and Talniflumate. The company was founded on July 20, 1999 and is headquartered in Jecheon-si, South Korea.

Boehringer Ingelheim KG, part of C.H. Boehringer Sohn AG & Co. KG, is a company headquartered in Biberach, Germany. The firm wholesales pharmaceutical products. It was founded in 1981.

Beijing Mediking Biopharm Co., Ltd. (‘Mediking’) is a leading API technology & manufacturing solutions provider. Driven by a responsible operations, ongoing innovation, and open collaboration, they have established their own Whole Process Quality Management System from lab-scale, pilot-scale to mass production. They also established their own database and platform about Chinese High technology source and also networks of cGMP factories. Their customers are TOP international generic pharmaceutical companies in more than 20 countries and regions. Mediking is committed to supporting their customers to be more competitive in their fields; Together with their customers, making the pharmaceutical industry to be more efficiency, clean and green.

Karuna Therapeutics is a biopharmaceutical company that develops treatments for psychiatric and neurological conditions. Karuna Therapeutics creates drugs that can significantly improve the lives of people who suffer from neurological and psychiatric illnesses, with a particular focus on schizophrenia and the behavioral symptoms of Alzheimer's disease. The company is skilled in neuroscience and has creative ideas for finding and developing new drugs. Karuna Therapeutics is advancing a pipeline of innovative drugs since its inception with the aim of significantly improving the lives of people suffering from these difficult conditions.

Beijing Huayao Kechuang Pharmaceutical Technology Development Co., Ltd., established on 2018-10-31, Business scope includes technical services,technology transfer,technology development,Technology Promotion,technical consulting;Undertake exhibition and display activities;Conference Services;Application software service(Does not contain medical software);software development.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Enaltec Labs Pvt Ltd., a subsidiary of La Renon Healthcare Pvt Ltd., is an Indian company located in Mumbai. The firm manufactures and supplies pharmaceutical products. It was founded in 2006. Anand Prafulchandra Shah is the current CEO of the firm. La Renon Healthcare Pvt Ltd. acquired Enaltec Labs Pvt Ltd. on January 20, 2022.